Peptides for Weight Loss: What Actually Has Evidence Behind It

"Peptides for weight loss" covers two categories that have almost nothing in common. One is approved medicines with large randomised trials behind them. The other is research compounds with no human efficacy data at all.

Both get sold, discussed, and searched for using the same phrase. Sorting them by what evidence exists is most of what a useful answer requires.

Tier one: approved, with large trials

These are the only two in the category with approval for weight management and head-to-head randomised evidence. The comparison covers what separates them, and the tirzepatide and semaglutide dosage charts cover the escalation schedules.

Tier two: investigational, real trial data

• Retatrutide — triple agonist, −24.2% at 48 weeks in phase 2. Not approved; phase 3 ongoing. See the dosage guide and side effects.

• Survodutide — GLP-1 plus glucagon, in phase 3. See the profile.

• CagriSema — amylin analogue combined with semaglutide, phase 3. See the profile.

These have genuine randomised evidence and no approval. That is a meaningfully different position from both tier one and everything below.

Tier three: no human efficacy evidence

These are widely sold and widely described as fat-loss compounds. None has a human trial establishing that:

Two of those five are not peptides at all. Tesofensine is a monoamine reuptake inhibitor with a stimulant-class risk profile, and 5-Amino-1MQ is an enzyme inhibitor. Grouping them under "peptides" obscures exactly what makes them different.

What the trial numbers do not tell you

• They are group means. The response range within each trial arm was wide.

• They came with monitoring. Trial participants were supervised, and escalation was managed.

• They describe pharmaceutical product. Not research-grade material of unverified content.

• They stop when the trial stops. What happens on discontinuation is a separate question.

Frequently asked questions

Which is the most effective?

Of approved options, tirzepatide produced greater mean reduction than semaglutide in the only head-to-head trial. Investigational compounds have reported larger figures in their own trials, which are not directly comparable.

Are any of these available without a prescription?

The approved ones are prescription medicines. Research-grade material is sold outside that channel, which is a supply question rather than an approval one — see are peptides legal.

Do you lose muscle as well as fat?

Substantial weight reduction from any cause includes lean mass. That is why resistance training and protein intake come up so consistently in this context.